Streetbeat News

Products Services

META

Meta Platforms Inc (NASDAQ:META) is in the spotlight ahead of its Q2 earnings report, expected to show earnings of $4.73 per share and revenue of $38.311 billion. The company has exceeded analyst estimates for five consecutive quarters. Analysts have mixed ratings, with price targets ranging from $500 to $575. AI performance and monetization strategy will be key focus areas.

Portfolio Pulse from Adam Eckert

July 31, 2024 | 3:22 pm

BWA

BorgWarner Inc (NYSE:BWA) shares are trading higher after reporting better-than-expected Q2 FY24 adjusted EPS and securing new contracts. Despite a 2% YoY sales decline to $3.603 billion, the company beat EPS estimates with $1.19 against the expected $1.01. BorgWarner also updated its FY24 sales and EPS guidance and announced a $300 million share repurchase plan.

Portfolio Pulse from Shivani Kumaresan

July 31, 2024 | 3:18 pm

COUR

GOOG

LVS

TSLA

This week in investing, key highlights include Coursera's strong earnings and AI course enrollment, Las Vegas Sands' misunderstood earnings, and the continued decline of the Magnificent 7 tech stocks. Coursera's stock surged 45% due to better-than-expected earnings and AI course growth. Las Vegas Sands faced a temporary decline due to room renovations but showed strong performance in Macau and Singapore. Alphabet and Tesla reported disappointing earnings, contributing to the tech sector's decline. The GDP and PCE reports suggest continued inflation, casting doubt on the likelihood of a September rate cut.

Portfolio Pulse from Gary Brode

July 31, 2024 | 3:18 pm

ABBV

Financial giants have shown a bullish stance on AbbVie (NYSE:ABBV) through options trading, with 13 call trades valued at $2,998,227 and 3 put trades valued at $162,020. Analysts have mixed ratings, with a consensus target price of $199.2. AbbVie is currently trading at $187.31, up by 0.28%.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:16 pm

LMT

Ukraine has received its first delivery of F-16 fighter jets, marking a significant milestone in its defense capabilities. This development is expected to have implications for defense contractors involved in the production and supply of these jets.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 3:05 pm

APLS

Traders are closely monitoring Apellis Pharmaceuticals after Jefferies circulated comments about an FDA FAERS update that included a new death related to Syfovre. Jefferies maintains that this does not change their view on Syfovre's safety.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:55 pm

BA

Boeing's CFO announced that the production of the 737 MAX reached approximately 25 units in June and July, as revealed during an analyst call.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:52 pm

ETHUSD

SOLUSD

A report by Flip Research claims that up to 93% of Solana's trading activity is non-organic, driven by wash trading, rug pulls, and exploitative MEV practices. The report suggests that Solana's metrics are inflated and that the ecosystem may be unsustainable in the long term.

Portfolio Pulse from Murtuza Merchant

July 31, 2024 | 2:46 pm

TEVA

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported strong Q2 2024 results, beating estimates and raising its annual outlook. The company saw significant growth in generic products and Austedo sales, leading to increased revenues and adjusted EPS. Teva also announced an accelerated development timeline for duvakitug.

Portfolio Pulse from Vandana Singh

July 31, 2024 | 2:38 pm

PEPG

PepGen shares are trading lower after the company announced clinical data from the first dose cohort of PGN-EDO51.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:21 pm